Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122498024 | 12249802 | 4 | F | 20160719 | 20160408 | 20160721 | EXP | KW-JNJFOC-20160406463 | JANSSEN | AL-HASHEL JY, ISMAIL II, JOHN JK, IBRAHIM M, ALI M. WORSENING OF MYASTHENIA GRAVIS AFTER ADMINISTRATION OF INJECTABLE LONG-ACTING RISPERIDONE FOR TREATMENT OF SCHIZOPHRENIA; FIRST CASE REPORT AND A CALL FOR CAUTION. NEUROMUSCULAR DISORDERS 2016;26(4-5):309-311. ISMAIL I. WORSENING OF MYASTHENIA GRAVIS AFTER ADMINISTRATION OF INJECTABLE LONG-ACTING RISPERIDONE FOR TREATMENT OF SCHIZOPHRENIA: FIRST CASE REPORT. EUROPEAN JOURNAL OF NEUROLOGY MAY-2016;23(2):324. | 29.00 | YR | A | F | Y | 0.00000 | 20160721 | MD | KW | KW |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122498024 | 12249802 | 1 | PS | RISPERIDONE. | RISPERIDONE | 1 | Intramuscular | Y | N | 21346 | 50 | MG | MICROSPHERES | QOW | |||||
| 122498024 | 12249802 | 2 | SS | INVEGA | PALIPERIDONE | 1 | Unknown | Y | U | UNKNOWN | 0 | 6 | MG | TABLETS | |||||
| 122498024 | 12249802 | 3 | SS | INVEGA | PALIPERIDONE | 1 | Unknown | Y | U | UNKNOWN | 21999 | 9 | MG | TABLETS | |||||
| 122498024 | 12249802 | 4 | I | FLUOXETINE | FLUOXETINE HYDROCHLORIDE | 1 | Unknown | U | 0 | 20 | MG | UNSPECIFIED | |||||||
| 122498024 | 12249802 | 5 | C | PYRIDOSTIGMINE | PYRIDOSTIGMINE | 1 | Unknown | 0 | 60 | MG | UNSPECIFIED | QID | |||||||
| 122498024 | 12249802 | 6 | C | AZATHIOPRINE. | AZATHIOPRINE | 1 | Unknown | 0 | 2.5 | MG/KG | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122498024 | 12249802 | 1 | Schizophrenia |
| 122498024 | 12249802 | 2 | Psychotic disorder |
| 122498024 | 12249802 | 3 | Psychotic disorder |
| 122498024 | 12249802 | 4 | Psychotic disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122498024 | 12249802 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122498024 | 12249802 | Drug interaction | |
| 122498024 | 12249802 | Myasthenia gravis | |
| 122498024 | 12249802 | Psychotic disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |